MHRA released six new guidance documents related to a no-deal scenario —five on importing and exporting medicines and active substances, and one on pediatric studies
Importing and exporting
- Importing medicines from an EEA State which is on an approved country for import list
- List of approved countries for authorised human medicines in a no deal scenario
- Guidance on importation of investigational medicinal products from approved countries
- Exporting active substance manufacturer in the UK if we leave the EU without a deal
- Guidance on air freight of medicines in a no deal scenario